Literature DB >> 28665010

Reduction in social activities mediates the relationship between diarrhea and distress in rectal/anal cancer survivors.

Catherine Benedict1, Katherine DuHamel2, Christian J Nelson2.   

Abstract

Entities:  

Year:  2017        PMID： 28665010      PMCID： PMC5748015          DOI： 10.1002/pon.4486

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  9 in total

1.  The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.

Authors:  M A Sprangers; A te Velde; N K Aaronson
Journal:  Eur J Cancer       Date:  1999-02       Impact factor: 9.162

2.  The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations.

Authors:  R M Baron; D A Kenny
Journal:  J Pers Soc Psychol       Date:  1986-12

3.  Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study.

Authors:  Lina Jansen; Antje Herrmann; Christa Stegmaier; Susanne Singer; Hermann Brenner; Volker Arndt
Journal:  J Clin Oncol       Date:  2011-07-18       Impact factor: 44.544

4.  Predictors of anxiety and depression in people with colorectal cancer.

Authors:  Nicola M Gray; Susan J Hall; Susan Browne; Marie Johnston; Amanda J Lee; Una Macleod; Elizabeth D Mitchell; Leslie Samuel; Neil C Campbell
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

5.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

6.  Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer.

Authors:  K J Emmertsen; S Laurberg
Journal:  Br J Surg       Date:  2013-09       Impact factor: 6.939

Review 7.  Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.

Authors:  K Fakhrian; T Sauer; A Dinkel; S Klemm; T Schuster; M Molls; H Geinitz
Journal:  Strahlenther Onkol       Date:  2013-05-02       Impact factor: 3.621

8.  The sexual health of female rectal and anal cancer survivors: results of a pilot randomized psycho-educational intervention trial.

Authors:  Katherine DuHamel; Tammy Schuler; Christian Nelson; Errol Philip; Larissa Temple; Leslie Schover; Raymond E Baser; Tatiana D Starr; Kathleen Cannon; Sabrina Jennings; Lina Jandorf; Jeanne Carter
Journal:  J Cancer Surviv       Date:  2015-12-14       Impact factor: 4.442

9.  Long term effect of surgery and radiotherapy for colorectal cancer on defecatory function and quality of life.

Authors:  Gillian Knowles; Rachel Haigh; Catriona McLean; Hamish A Phillips; Malcolm G Dunlop; Farhat V N Din
Journal:  Eur J Oncol Nurs       Date:  2013-02-27       Impact factor: 2.398
  9 in total
  2 in total

1.  Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer From SOLAR-1.

Authors:  Eva Maria Ciruelos; Hope S Rugo; Ingrid A Mayer; Christelle Levy; Frédéric Forget; Juan Ignacio Delgado Mingorance; Tamar Safra; Norikazu Masuda; Yeon Hee Park; Dejan Juric; Pierfranco Conte; Mario Campone; Sibylle Loibl; Hiroji Iwata; Xiaolei Zhou; Jinhee Park; Antonia Ridolfi; Ines Lorenzo; Fabrice André
Journal:  J Clin Oncol       Date:  2021-03-29       Impact factor: 50.717

2.  The development and initial evaluation of the Diarrhoea Management Diary (DMD) in patients with metastatic breast cancer.

Authors:  Helena Harder; Valerie M Shilling; Shirley F May; David Cella; Peter Schmid; Lesley J Fallowfield
Journal:  Breast Cancer Res Treat       Date:  2020-07-27       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.